Structure–activity relationship for human cytochrome P450 substrates and inhibitors

REFERENCES

• Nelson D.R., Koymans L., Kamataki T., Stegeman J.J., Feyereisen R., Waxman D.J., Waterman M.R., Gotoh O., Coon M.J., Estabrook R.W., Gunsalus I.C., Nebert D.W. P450 Superfamily: Update on New Sequences, Gene Mapping, Accession Numbers and Nomenclature. Pharmacogenetics 1996; 6: 1–42
   PubMedGoogle Scholar
• Ioannides C. Cytochromes P450: Metabolic and Toxicological Aspects. CRC Press, Boca Raton, FL 1996
   Google Scholar
• Lewis D.F.V. Cytochromes P450: Structure, Function and Mechanism. Taylor and Francis, London 1996
   Google Scholar
• Rendic S., DiCarlo F.J. Human Cytochrome P450 Enzymes: a Status Report Summarizing Their Reactions, Substrates, Inducers and Inhibitors. Drug Metab. Rev. 1997; 29: 413–580
   PubMed Web of Science ®Google Scholar
• Smith D.A., Abel S.M., Hyland R., Jones B.C. Human Cytochrome P450s: Selectivity and Measurement In Vivo. Xenobiotica 1998; 28: 1095–1128
   PubMed Web of Science ®Google Scholar
• Guengerich F.P. Human Cytochrome P450 Enzymes. Cytochrome P450, P.R. Ortiz de Montellano. Plenum Press, New York 1995; 473–535
   Google Scholar
• Lewis D.F.V., Eddershaw P.J., Dickins M., Tarbit M.H., Goldfarb P.S. Structural Determinants of P450 Substrate Specificity. Chem. Biol. Interact. 1998; 115: 175–199
   PubMed Web of Science ®Google Scholar
• Lewis D.F.V. On the Recognition of Mammalian Microsomal Cytochrome P450 Substrates and Their Characteristics. Biochem. Pharmacol. 2000; 60: 293–306
   PubMed Web of Science ®Google Scholar
• Lewis D.F.V. Structural Characteristics of Human P450s Involved in Drug Metabolism: QSARs and Lipophilicity Profiles. Toxicology 2000; 144: 197–203
   PubMed Web of Science ®Google Scholar
• Lewis D.F.V. Modeling Human Cytochromes P450 for Evaluating Drug Metabolism. Drug Metab. Drug Interact. 2000; 16: 307–324
   PubMedGoogle Scholar
• Lewis D.F.V., Dickins M., Eddershaw P.J., Tarbit M.H., Goldfarb P.S. Cytochrome P450 Substrates Specificities, Substrate Structural Templates and Enzyme Active Site Geometries. Drug Metab. Drug Interact. 1999; 15: 1–49
   PubMedGoogle Scholar
• Ekins S., de Groot M., Jones J.P. Pharmacophore and Three-Dimensional Quantitative Structure–Activity Relationship Methods for Modeling Cytochrome P450 Active Site. Drug Metab. Dispos., in press
   Web of Science ®Google Scholar
• Smith D.A., Ackland M.J., Jones B.C. Properties of Cytochrome P450 Isoenzymes and Their Substrates. Part 1: Active Site Characteristics. Drug Discov. Today 1997; 2: 406–414
   Web of Science ®Google Scholar
• Smith D.A., Ackland M.J., Jones B.C. Properties of Cytochrome P450 Isoenzymes and Their Substrates. Part 2: Properties of Cytochrome P450 Substrates. Drug Discov. Today 1997; 2: 479–486
   Web of Science ®Google Scholar
• Lewis D.F.V., Lake B.G., George S.G., Dickins M., Eddershaw P.J., Tarbit M.H., Beresford A.P., Goldfarb P.S., Guengerich F.P. Molecular Modeling of CYP1 Family Enzymes CYP1A1, CYP1A2, CYP1A6 and CYP1B1 Based on Sequence Homology with CYP102. Toxicology 1999; 139: 53–79
   PubMed Web of Science ®Google Scholar
• Lewis D.F.V., Dickins M., Lake B.G., Eddershaw P.J., Tarbit M.H., Goldfarb P.S. Moleculer Modeling of the Human Cytochrome P450 Isoform CYP2A6 and Investigations of CYP2A Substrate Selectivity. Toxicology 1999; 133: 1–33
   PubMed Web of Science ®Google Scholar
• Lewis D.F.V., Lake B.G., Dickins M., Eddershaw P.J., Tarbit M.H., Goldfarb P.S. Molecular Modeling of CYP2B6, the Human CYP2B Isoform, by Homology with the Substrate-Bound CYP102 Crystal Structure: Evaluation of CYP2B6 Substrate Characteristics, the Cytochrome b5 Binding Site and Comparisons with CYP2B1 and CYP2B4. Xenobiotica 1999; 29: 361–393
   PubMed Web of Science ®Google Scholar
• Lewis D.F.V., Dickins M., Weaver R.J., Eddershaw P.J., Goldfarb P.S., Tarbit M.H. Molecular Modeling of Human CYP2C Subfamily Enzymes CYP2C9 and CYP2C19: Rationalization of Enzyme Specificity and Site-Directed Mutagenesis Experiments in the CYP2C Subfamily. Xenobiotica 1998; 28: 235–268
   PubMed Web of Science ®Google Scholar
• Lewis D.F.V., Eddershaw P.J., Goldfarb P.S., Tarbit M.H. Molecular Modeling of Cytochrome P4502D6 (CYP2D6) Based on an Alignment with CYP102: Structural Studies on Specific CYP2D6 Substrate Metabolism. Xenobiotica 1997; 27: 319–340
   PubMed Web of Science ®Google Scholar
• Lewis D.F.V., Bird M.G., Dickins M., Lake B.G., Eddershaw P.J., Tarbit M.H., Goldfarb P.S. Molecular Modeling of Human CYP2E1 by Homology with the CYP102 Hemoprotein Domain: Investigation of the Interactions of Substrates and Inhibitors Within the Putative Active Site of the Human CYP2E1 Isoform. Xenobiotica 2000; 30: 1–25
   PubMed Web of Science ®Google Scholar
• Lewis D.F.V., Eddershaw P.J., Goldfarb P.S., Tarbit M.H. Molecular Modeling of CYP3A4 from an Alignment with CYP102: Identification of Key Interactions Between Putative Active Site Residues and CYP3A-Specific Chemicals. Xenobiotica 1996; 26: 1067–1086
   PubMed Web of Science ®Google Scholar
• Brown, D. P450: Enzymes with the Answers on Drug Risks. The Washington Post, April 10, 2000, p. A9.
   Google Scholar
• Sata F., Sapone A., Elizando G., Stocker P., Miller V.P., Zheng W., Raunio H., Crespi C.L., Gonzalez F.J. CYP3A4 Allelic Variants with Amino Acid Substitutions in Exons 7 and 12: Evidence for an Allelic Variant with Altered Catalytic Activity. Clin. Pharmacol. Ther. 2000; 67: 48–56
   PubMed Web of Science ®Google Scholar
• Eddershaw P.J., Dickins M. Advances in In Vitro Drug Metabolism Screening. Pharm. Sci. Technol. Today 1999; 2: 13–19
   PubMedGoogle Scholar
• Lewis D.F.V., Pratt J.M. The P450 Catalytic Cycle and Oxygenation Mechanism. Drug Metab. Rev. 1998; 30: 739–786
   PubMed Web of Science ®Google Scholar
• Schlichting I., Berendzen J., Chu K., Stock A.M., Maves S.A., Benson D.E., Sweet R.M., Ringe D., Petsko G.A., Sligar S.G. The Catalytic Pathway of Cytochrome P450cam at Atomic Resolution. Science 2000; 287: 1615–1622
   PubMed Web of Science ®Google Scholar
• Lewis D.F.V., Hlavica P. Interactions Between Redox Partners in Various Cytochrome P450 Systems: Functional and Structural Aspects. Biochim. Biophys. Acta 2000; 1460: 353–374
   PubMed Web of Science ®Google Scholar
• Lewis, D.F.D. A Guide to Cytochrome P450 Structure and Function; Taylor and Francis: London, 2001.
   Google Scholar